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Obesity triggers an innate and adaptive
immune response in adipose tissue, but
little is known about how these signals
are coordinated. Cho et al. demonstrate
the importance of MHC II class-restricted
signals from adipose tissuemacrophages
in controlling obesity-induced T cell acti-
vation and the development of insulin
resistance. Loss of MHC II from resident
tissue macrophages is sufficient to pre-
vent the generation of active effector/
memory T cells identifying a target for
intervention in metainflammation.
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An adaptive immune response triggered by obesity
is characterized by the activation of adipose tissue
CD4+ T cells by unclear mechanisms.We have exam-
ined whether interactions between adipose tissue
macrophages (ATMs) and CD4+ T cells contribute
to adipose tissue metainflammation. Intravital micro-
scopy identifies dynamic antigen-dependent interac-
tions between ATMs and T cells in visceral fat. Mice
deficient in major histocompatibility complex class
II (MHC II) showed protection from diet-induced
obesity. Deletion of MHC II expression in macro-
phages led to an adipose tissue-specific decrease
in the effector/memory CD4+ T cells, attenuation
of CD11c+ ATM accumulation, and improvement
in glucose intolerance by increasing adipose tissue
insulin sensitivity. Ablation experiments demon-
strated that the maintenance of proliferating conven-
tional T cells is dependent on signals from CD11c+
ATMs in obese mice. These studies demonstrate
the importance of MHCII-restricted signals from
ATMs that regulate adipose tissue T cell maturation
and metainflammation.
INTRODUCTION
Obesity-induced adipose tissue inflammation is controlled by
a diverse network of leukocytes comprised of multiple cellular
regulators of innate and adaptive immunity (Mathis, 2013). One
component of the metainflammatory response to obesity is an
alteration in the state of adipose tissue T cells (ATTs) that influ-
ences the inflammatory set point of adipose tissue and insulin
sensitivity. Adipose tissue contains a unique population of
resident regulatory T cells (Treg) that is prominent in lean states
and has a protective influence on adipose tissue inflammation
in obesity (Cipolletta et al., 2012; Deiuliis et al., 2011; FeuererCet al., 2009). While Tregs are downregulated with obesity, con-
ventional Th1 T cells (Tconv) accumulate in visceral fat depots
and contribute to proinflammatory signals in adipose tissue
(Khan et al., 2014; Stolarczyk et al., 2013; Winer et al., 2009).
The ability of Th1 ATTs to promote obesity-induced inflammation
is dependent on ab T cell receptors (TCRs), T-bet, STAT3, and
interferon g (IFNg) (Khan et al., 2014; O’Rourke et al., 2012;
Priceman et al., 2013; Rocha et al., 2008; Stolarczyk et al.,
2013). Th17 and Th22 cells in adipose tissue have also been
associated with insulin resistance in obese individuals (Bertola
et al., 2012; Fabbrini et al., 2013).
The signals that control the activation and maintenance of the
ATTs are not well understood. Obesity induces ATT proliferation,
suggesting that ATTs are stimulated by signals from the adipose
tissue environment (Moraes-Vieira et al., 2014; Morris et al.,
2013). Both Treg and Tconv have a limited repertoire of TCRs,
suggesting that clonal T cell selection shapes adipose tissue
lymphocytes (Feuerer et al., 2009; Yang et al., 2010). Compared
with secondary lymphoid tissues, adipose tissue contains few
naive T cells and a high percentage of effector/memory type
CD4+ T cells that regulate adaptive immunity based on interac-
tions with antigen-presenting cells (APCs) (Reis e Sousa, 2006;
Vandanmagsar et al., 2011; Yang et al., 2010; Zhu and Paul,
2008). APCs integrate multiple signaling pathways in tissues, re-
sulting in the maturation of naive T cells toward a specific activa-
tion profile. For CD4+ T cells, a core component of thematuration
process is the presentation of antigens via major histocompati-
bility complex II (MHC II), which binds to the TCR.
Several lines of evidence suggest that APCs partner with
T cells in adipose tissue to control metainflammation. Global
deficiency of MHC II protects mice from obesity-induced obesity
and inflammation (Deng et al., 2013). Conversely, enhancing
APC function in fat by injection of activated bone marrow-
derived dendritic cells into mice promotes adipose tissue inflam-
mation and induces insulin resistance (Moraes-Vieira et al., 2014;
Stefanovic-Racic et al., 2012). Adipokines such as leptin, adipo-
nectin, and RBP4 activate APCs and promote Th1 T cell activa-
tion (Jung et al., 2012; Mattioli et al., 2005; Moraes-Vieira et al.,
2014). APC signals also play a role in the maintenance ofell Reports 9, 605–617, October 23, 2014 ª2014 The Authors 605
Figure 1. ATMs Physically Interact with CD4+ T Cells in an Antigen-Dependent Manner
(A) Immunofluorescence analysis of MHC II+ cells (red) in FALC regions of mouse adipose tissue.
(B) Immunofluorescence analysis of HLA-DR+ (red) cells in human omental tissue. Representative images are presented from similar results from five independent
samples.
(C) Maximum intensity projection of z stacks in FALCs in eWAT from CD11c-mCherry mice adoptively transferred with CFSE-CD4+ cells.
(D) Time-lapse images of interacting CD11c+ ATMs (red) and OTII CD4+ T cells (green) in eWAT from CD11c-mCherry mice injected with BSA (upper) or OVA
(lower). Imaging of adipose tissue performed with intravital multiphoton confocal microscopy over a 20 min imaging window.
(legend continued on next page)
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protective adipose tissue Tregs. B7-deficient mice that lack cos-
timulatory molecules CD80 and CD86 have reduced Tregs sys-
temically and in adipose tissue and demonstrate worse adipose
tissue inflammation (Zhong et al., 2014).
While APCs may shape ATTs, ATTs can also influence the
recruitment and activation of adipose tissue macrophages
(ATMs). ATT activation precedes the prominent accumulation
of proinflammatory CD11c+ ATMs induced by chronic obesity
(Nishimura et al., 2009; Winer et al., 2009). This observation im-
plies that the machinery required to activate ATTs in response
to obesity must be native to adipose tissue and exist prior to
the onset of obesity. In all adipose depots in lean mice and
humans, the most prominent professional APCs are the exten-
sive network of MHC II+-resident ATMs (Lumeng et al., 2007;
Odegaard and Chawla, 2011). Resident ATMs express markers
of alternatively activated macrophages (CD206 and CD301/
MGL1) do not express the activation marker CD11c (CD11c)
and are concentrated in fat-associated lymphoid clusters
(FALCs) and omental milky spots (Morris et al., 2013; Rangel-
Moreno et al., 2009).
Work from our group and others has shown that ATMs are
functional APCs that can promote antigen-specific T cell activa-
tion ex vivo and in adipose tissue (Bertola et al., 2012; Morris
et al., 2013; Stefanovic-Racic et al., 2012). However, several un-
resolved questions remain regarding if MHC II-restricted signals
from ATMs are required for the activation of CD4+ T cells in
adipose tissue, the importance of MHC II signals in insulin resis-
tance, and which subtype of ATM (resident or recruited CD11c+)
is required for initiating an adaptive immune response to obesity.
The goal of this study was to investigate the role that ATMs play
in directing CD4+ ATT activation, adipose tissue inflammation,
and insulin resistance in vivo. We reveal a dynamic and anti-
gen-dependent network of immune surveillance driven by inter-
actions between ATMs and ATTs in visceral adipose tissue
in vivo. Interruption of communication between resident tissue
ATMs and ATTs via macrophage-specific deletion of MHC II
does not alter ATTs in lean states, but prevents the generation
of effector/memory ATTs and adipose tissue insulin resistance
with obesity. Ablation of CD11c+ cells in obese mice support
the importance of CD11c+ ATMs in maintaining Tconv at the
expense of Treg. Overall, our studies identify a critical MHC
II-restricted activation loop between resident CD11c ATMs,
ATTs, and CD11c+ ATMs that contributes to metainflammation.
RESULTS
CD4+ T Cells Demonstrate Antigen-Dependent
Interactions with ATMs In Vivo
We have previously identified high concentrations of CD4+ ATTs
in FALC structures in visceral adipose tissue that are also en-
riched for MHC II+ CX3CR1+ ATMs (Morris et al., 2013). To better
delineate relationship between CD4+ T cells and ATMs in FALCs,(E) CD4+ T cell migration pathways in adipose tissue from mice injected with BS
(F and G) Velocity (F) and displacement lengths (G) of individual CD4+ T cells in
(H) Percentage of CD4+ T cells interacting with CD11c+ cells in eWAT. Microsco
Data are means ± SEM. **p < 0.01, ***p < 0.001 versus BSA.
Cwe performed confocal microscopy on whole-mount adipose
tissue samples. FALCs containedMgl1+ ATMs that coexpressed
MHC II (Figure 1A). MHC II was not identified in caveolin+ adipo-
cytes in lean or high-fat diet (HFD)-fed obese mice. Imaging of
human omental adipose tissue from obese patients undergoing
bariatric surgery identified milky spots enriched for CD206+
HLA-DR+ ATMs (Figure 1B). HLA-DR+ cells were in direct con-
tact with HLA-DR CD4+ T cells in milky spots. As in mice, no
HLA-DR staining was observed in association with adipocytes.
We employed live intravital microscopy to evaluate the dy-
namic interactions between ATMs and CD4+ ATTs in vivo.
CFSE-labeled CD4+ T cells from OT-II mice were injected intra-
peritoneal (IP) into CD11c-mCherry reporter mice that permitted
identification of endogenous myeloid cells (Khanna et al., 2010).
Flow cytometry demonstrated that the mCherry+ cells were F4/
80+ CD11b+ ATMs in lean mice (Figure S1A). At 24 hr after injec-
tion, recipient mice were anesthetized, and epididymal white
adipose tissue (eWAT) was externalized for imaging. More than
20% CD4+ T cells isolated from eWAT were CFSE+ (15% of
injected cells were recovered in adipose tissue) and concen-
trated in FALC structures (Figures 1C, S1B, and S1C). Cells
were imaged by multiphoton confocal microscopy for 20 min.
While mCherry+ cells did not demonstrate significant motility,
the CD4+ T cells were highly motile (mean velocity = 5.6 mm/min)
and showed random movement within the FALC structure (Fig-
ures 1D and 1E; Movie S1).
The interactions between CD4+ T cells and APCs are
increased in the presence of a cognate T cell-specific antigen
(Halin et al., 2005; Koltsova et al., 2012). To examine this in adi-
pose tissue, CD11c-mCherry mice were injected IP with CFSE-
labeled CD4+ OT-II T cells followed by injection of ovalbumin
(OVA) or BSA control. After 2 hr, CD4+ T cell velocity and path
of movement were assessed with intravital microscopy (Figures
1F and 1G). In BSA-injected mice, the velocity of CD4+ T cells
and displacement length were 5.53 ± 0.36 mm/min and 25.14 ±
0.52 mm, respectively, over 20 min. In control mice, less than
20% of the T cells directly interacted with mCherry+ cells based
on colocalization (Figure 1H). Among themotile CD4+ cells,2%
of the cells showed distinct high-velocity motile behavior. With
OVA injection, long-lived T cell-CD11c+ cells interactions were
induced, and 60% of the CD4+ T cells maintained stable con-
tact with the mCherry+ cells over 20 min (Figure 1H; Movie S2).
With OVA, the average speed (2.2 ± 0.14 mm/min) and mean
displacement length (BSA versus OVA: 25.15 ± 0.52 versus
14.73 ± 1.2 mm; p < 0.05) of CD4+ T cells were decreased
compared with controls. The reduction in migration velocity
with OVA was due to a reduction in mean individual T cell motility
aswell as the loss of the high-motility T cells seen in control mice.
In summary, intravital imaging demonstrates that dynamic inter-
actions between ATMs and CD4+ T cells in adipose tissue are
constantly occurring in adipose tissue and such interactions
are stabilized and enhanced in an antigen-dependent manner.A (upper) or OVA (lower).
eWAT.
py data are representative of three independent experiments.
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Figure 2. MHC II-Deficient Mice Are Protected from HFD-Induced Insulin Resistance through the Reduction of ATMs and CD4+ ATT
Accumulation
MHC IIKO (KO) and WT control male mice were fed ND or HFD for 20 weeks.
(A) Body weights of WT and MHC IIKO (KO) mice during ND and HFD feeding (ND, n = 6; HFD, n = 8).
(B) Body composition analysis of fat and lean mass in WT and KO mice as determined by NMR. The right panel shows normalization to total body weight.
(C) Organ weights at the end of the diet exposure.
(D) Immunofluorescence identification of Mac2+ ATMs in eWAT from HFD-fed WT and KO mice. Scale bar represents 200 mm.
(E) Adipocyte size and adipocyte size distribution in eWAT from HFD-fed WT and KO mice.
(F and G) Analysis of glucose metabolism by (F) GTTs and (G) ITTs.
(H) Quantitation of total, CD11c+, and CD11c ATMs (CD11b+F480+) in eWAT from WT and KO mice by flow cytometry.
(I) Quantitation of CD3+ CD4+ and CD3+ CD8+ ATTs (left), Tconv and Treg (right) in eWAT in WT and KO mice.
(J) Quantitation of blood CD3+ CD4+ and CD3+ CD8+ T lymphocytes from WT and KO mice.
Data are shown as means ± SEM; #p < 0.05 in one-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001 versus WT.MHC II Is Required for HFD-Induced Adipose Tissue
Inflammation and Insulin Resistance
Given that MHC II is required for cell-mediated immunity
through CD4+ T cells, we examined the requirement for MHC
II in the generation of obesity-induced inflammation by studying
MHC II-deficient mice (H2-Ab1/, MHC II KO). Lean MHC II KO
mice weighed less then age-matched wild-type (WT) mice and
gained less weight with age (Figure 2A). When challenged with
a HFD for 20 weeks, MHC II KO mice gained weight at a
reduced rate compared with WT controls (WT 27.8 ± 0.6 g;
MHC II KO 20.6 ± 1.2 g; p < 0.01). Metabolic cage analysis
did not identify any differences in food intake, energy expendi-
ture, or body length between genotypes in either diet condition
(Figure S2). A body composition analysis showed that the
weight differences between genotypes were due to a decrease
in lean body mass, but not fat mass, in normal diet (ND) and
HFD MHC II KO mice (Figure 2B). When body composition
was expressed as a percentage of total body mass, there
were no differences between genotypes in ND and HFD condi-608 Cell Reports 9, 605–617, October 23, 2014 ª2014 The Authorstions. Tissue weights at sacrifice demonstrated significantly
more visceral adiposity in HFD-fed MHC II KO compared with
WT (Figure 2C). HFD-fed WT and MHC II KO mice demon-
strated similar hypertrophy of inguinal/subcutaneous fat depots
(sWAT). HFD-fed mice demonstrated a significant accumulation
of Mac2+ crown-like structures (CLSs) in WT eWAT, while CLSs
were largely absent in MHC II KO adipose tissue, consistent
with a preservation of adipose tissue health and low inflamma-
tion (Figure 2D). Adipocyte size did not differ between HFD-fed
WT and MHC II KO mice. (Figure 2E). Liver weights of MHC II
KO mice were significantly less than WT mice in both dietary
conditions, and a HFD did not induce an increase in liver weight
in MHC II KO mice (Figure 2C). HFD MHC II KO mice were
protected from histologic steatosis and liver triglyceride accu-
mulation (Figure S3A). This protection was associated with a
significant decrease in hepatic Scd1 and Fasn expression in
MHC II KO mice (Figure S3D).
Glucose and insulin tolerance were not altered in ND-fed
MHC II KO mice (Figures 2F and 2G). Despite an increase in
visceral adipose tissue, obese MHC II KO mice had improved
glucose and insulin tolerance compared with HFD WT mice. In-
sulin levels and free fatty acids were significantly lower in obese
MHC II KO mice compared with WT (Figure S3B). Gene expres-
sion analysis of eWAT fromHFDmice showed increased expres-
sion of genes associated with adipocyte insulin sensitivity (e.g.,
Glut4, Pparg, and Adipoq) in MHC II KO mice compared with
WT (Figure S3C). In addition, MHC II KOmice showed decreased
expression of Ifng in eWAT, indicating that MHC II-restricted sig-
nals are required for maximal Ifng induction with obesity. In liver,
there were no significant differences in Ifng, Tnfa, Il6, or Foxp3
gene expression between WT and MHC II KO mice in response
to HFD (Figure S3D). Overall, these data demonstrate that MHC
II-dependent signals contribute to insulin resistance with diet-
induced obesity by promoting adipose tissue dysfunction and
hepatic lipid accumulation.
MHC II Deficiency Reduces the Accumulation of CD11c+
ATMs and CD4+ ATTs, but Not CD8+ ATTs, in Response
to HFD
To examine the effects of MHC II on leukocyte infiltration into
visceral fat, ATM and ATT content was assessed by flow cytom-
etry in eWAT from WT or MHC II KO mice. Consistent with the
imaging data, MHC II KO mice had fewer ATMs due to a
decrease in the percentage of CD11c+ ATMs (Figure 2H). The
reduction in CD11c+ ATM accumulation could not be explained
by reduced MCP-1 or reduced circulating monocyte levels,
as Ccl2 expression in eWAT and the content of 7/4hi blood
monocytes were similar between HFD-fed WT and MHC II KO
mice (Figures S3C and S3E). Consistent with the importance
of MHC II in thymic selection of CD4+ T cells, MHC II KO
mice had a significant reduction in CD4+ lymphocytes in the
blood, spleen, and adipose tissue compared with WT mice
in both diet conditions (Figures 2I and 2J; data not shown).
A substantial reduction of CD4+ ATTs as a percent of stromal
vascular cells (SVCs) was seen for both Tconv (CD4+ FoxP3)
as well as Tregs (CD4+ FoxP3+). CD8+ T cells were significantly
increased systemically and in adipose tissue of MHC II KOmice.
These results suggest that neither an increase in CD8+ ATTs
nor a reduction in Tregs alone is sufficient to generate maximal
adipose tissue inflammation and insulin resistance and sug-
gest an important role for MHC II-dependent Tconv in obesity-
induced inflammation.
Macrophage-Specific MHC II-Deficient Mice Show
Improved Insulin Sensitivity in Response to HFD
The systemic depletion of CD4+ cells in whole-body MHC II KO
mice does not let us discern the role of adipose tissue-specific
MHC II in regulating T cells. To address this, initial experiments
attempted to delete MHC II expression in hematopoietic cells
via bone marrow transplantation of MHC II/ donors into WT
recipients. However, similar to other reports (Marguerat et al.,
1999), these mice developed an autoimmune phenotype with
severe weight loss that limited our ability to assess metabolic
responses (data not shown).
Resident CD301+ ATMs are the dominant professional APC
in adipose tissue by quantity in lean states and are thus poised
to initiate T cell activation in response to obesogenic signalsC(Bertola et al., 2012; Stefanovic-Racic et al., 2012). To evaluate
the hypothesis that MHC II signals from resident ATMs are
required for obesity-induced activation of CD4+ ATTs, we gener-
ated macrophage-specific MHC II knockout (MMKO) mice.
LysM-Cre mice were crossed to mice with flox sequences flank-
ing exon 1 of the H2-ab1 gene (H2-Ab1tm1Koni; MHC IIf/f). Flow
cytometry confirmed MHC II expression in both ATMs and
adipose tissue dendritic cells (ATDCs) in MHC IIf/f control mice.
In this experiment, the macrophage-specific marker CD64 was
used to identify ATMs (resident CD45+ CD64+ CD11c and re-
cruitedCD45+CD64+CD11c+) and distinguish them fromATDCs
(CD45+ CD64 CD11c+) (Gautier et al., 2012) (Figure 3A). Lean
MMKO did not demonstrate any differences in the quantity of
ATMs or ATDCs in eWAT compared with controls (Figure 3B).
However, MHC II expression was absent in >95% of the ATMs
of MMKO mice and remained intact in a small but prominent
population of ATDCs. Immunostaining of adipose tissue
confirmed deletion of MHC II in MGL1+ resident ATMs in
MMKO mice (Figure 3C). Expression of MHCII (H2-ab1) in
eWATwas decreased by >95% inMMKOmice without changing
Emr1, CD40, or CD80 expression demonstrating that LysM-cre
expressing cells account for the vast majority of MHCII expres-
sion in adipose tissue (Figure 3D). MMKO mice had normal
numbers of circulating neutrophils and monocytes, indicating
that the macrophage MHC II is not required for the proper main-
tenance of myeloid cells (Figure 3E). Importantly, there were
no changes in CD4+ or CD8+ T cells in the thymus, spleen, and
lymph nodes of MMKO mice, demonstrating that macrophage
MHC II is dispensable for normal T cell maturation in lymphoid
tissues (Figure 3F).
To determine the importance of macrophage MHC II in
glucose metabolism, control and MMKO mice were fed with
ND or HFD for 14 weeks. MMKOmice were healthy and demon-
strated weight gain with HFD that was identical to control mice
(Figure 4A), suggesting that macrophage MHC II does not
account for the growth defects observed in whole-body MHC
IIKO mice. eWAT hypertrophy on HFD was similar between
control and MMKO mice (Figure 4B). Fasting glucose and
insulin levels did not differ between ND-fed control and MMKO
mice (Figure 4C). HFD-fed MMKO mice showed a significant
decrease in fasting glucose levels compared with control mice,
although fasting insulin levels were similar. Glucose tolerance
tests (GTTs) and insulin tolerance tests (ITTs) did not differ
between ND-fed control and MMKO mice (Figures 4D and 4E).
However, when challenged with HFD, MMKO mice had sig-
nificantly improved glucose tolerance and insulin sensitivity
compared with controls.
Immunofluorescence microscopy showed a reduction in
CLSs in eWAT from obese MMKO mice compared with con-
trols without differences in adipocyte size (Figures 4F and
4G). To evaluate the mechanisms of improved insulin sensitivity
in MMKO mice, adipose tissue and liver insulin signal trans-
duction was evaluated in obese mice. Consistent with the
decrease in CLSs, HFD-fed MMKO mice demonstrated a sig-
nificant increase in Akt phosphorylation in eWAT in response
to insulin compared with WT mice (Figure 4H). Insulin-stimu-
lated Akt phosphorylation in the liver was marginally increased
in MMKO mice compared with controls (Figure 4I). Geneell Reports 9, 605–617, October 23, 2014 ª2014 The Authors 609
Figure 3. Generation of Macrophage-Specific MMKO Mice
(A) Representative flow cytometry plots of MHC II-expressing cells in eWAT SVCs. ATMs (CD45+ CD64+) (upper panels) and ATDCs (CD45+ CD64 CD11c+)
(lower) from control (CON) and MMKO mice.
(B) Quantitation of ATMs and ATDCs (upper) and frequency of MHC II+ cells in ATMs and ATDCs (lower) fromCON andMMKOmice. Fivemice were assessed per
group in four independent cohorts.
(C) Immunofluorescence images showing loss of MHC II+ expression in (green) and resident Mgl1+ ATMs (red). Scale bar represents 50 mm.
(D) Quantitative PCR analysis of eWAT from CON and MMKO mice.
(E) Quantitation of total blood myeloid cells and total lymphocytes.
(F) Frequency of CD4+ and CD8+ T lymphocytes in thymus, spleen, and mesenteric lymph nodes (mLNs).
Data are means ± SEM. ***p < 0.001 versus CON.expression from whole adipose tissue demonstrated a signifi-
cant increase in adiponectin (Adipoq) and Glut4 expression in
EWAT from obese MMKO mice compared with WT (Figure 4J).
These observations indicate that MMKO mice are protected
from insulin resistance by improvements in adipose tissue insu-
lin sensitivity.610 Cell Reports 9, 605–617, October 23, 2014 ª2014 The AuthorsAccumulation of CD11c+ ATMs in Visceral Fat Is
Attenuated in MMKO Mice
To examine the cellular mechanisms involved in the improved
metabolism of MMKO mice, ATM and ATDC content was
analyzed by flow cytometry (Figure 5A). Therewere no significant
differences in total ATMs or ATDCs in eWAT between control
Figure 4. Macrophage-Specific MHC II Knockout Mice Have Attenuated HFD-Induced Insulin Resistance due to Improved Adipose Tissue
Insulin Sensitivity
Metabolic assessment of MMKO and control mice fed ND or HFD for 14 weeks (n = 10–12 for each group).
(A) Body weight.
(B) eWAT weight.
(C) Fasting glucose (left) and insulin levels (right).
(D and E) GTT (D) and ITT (E) performed at 12 weeks of diet exposure.
(F) Immunofluorescence image of Mac2+ ATM (red) and caveolin+ adipocytes (green) in eWAT fromHFD fed CON andMMKOmice. Scale bar represents 100 mm.
(G) Quantitation of adipocyte size in eWAT from HFD-fed CON and MMKO. At 12 weeks after HFD feeding, tissues were harvested from CON and MMKO mice
5 min after intravenous injection of saline or insulin.
(H and I) Immunoblots of lysates from eWAT (H) and liver (I) with anti-pSer473 or anti-Akt (upper) and quantitation of phosphorylated AKT normalized to total AKT
levels (lower).
(J) Gene expression in eWAT from HFD fed CON and MMKO.
Data are means ± SEM. *p < 0.05, **p < 0.01 versus CON.and MMKO mice in lean or obese states (Figure 5B). In ND-fed
mice, the quantity of CD11c+ and CD11c resident ATMs as a
percentage of SVCs did not differ between genotypes. However,
with HFD, obese MMKO mice had significantly fewer CD11c+
ATMs compared with controls. No changes in the quantity of
resident CD11c ATMs were observed in MMKOmice, resulting
in an overall decrease in the ratio of CD11c+ to CD11c ATMs in
obese MMKO mice (Figure 5C). Consistent with this, the M1
macrophage marker Nos2 was decreased in eWAT, and the
alternatively activated macrophage marker Arg1 showed a trend
toward an increase (Figure 5D). To evaluate whether differences
in proliferation account for the decrease in CD11c+ ATMs, tissue
sections were stained with Ki67. No differences in Ki67+ cells inCthe ATM-enriched CLSs were observed (Figure 5E). Analysis of
serum from obese mice identified a significant decrease in
MCP-1 levels in MMKO mice compared with WT controls (Fig-
ure 5F). Bone marrow-derived macrophages were generated
from WT and MMKO mice, and no differences in inflammatory
gene expression in response to lipopolysaccharide (LPS) were
observed, suggesting that MHC II is not required for macro-
phage activation (Figure 5G). In agreement with the lower
MCP-1 and ATM accumulation, expression of genes associated
with inflammation such as Tnfa and Il10 in eWAT and liver from
obeseMMKOwas decreased compared with obeseWT controls
(Figures S4A and S4B). Collectively, these results indicate that
the presence of MHC II on resident ATMs is required for maximalell Reports 9, 605–617, October 23, 2014 ª2014 The Authors 611
Figure 5. Macrophage-Specific MHC II
Deficiency Reduced HFD-Induced CD11c+
ATMs Accumulation in Visceral Fat
(A) Representative flow cytometry plots of CD45+
cells in SVC from eWAT from HFD-fed CON and
MMKO. ATMs (CD45+ CD64+) are differentiated
based on CD11c expression. ATDCs are defined
as CD64 CD11c+.
(B) Quantitation of ATM and ATDC content in
eWAT.
(C) Frequency of CD11c+ ATMs and CD11c
ATMs (left) and the ratio of CD11c+ ATMs to
CD11c ATMs (right) in eWAT.
(D) Gene expression in eWAT from HFD-fed CON
and MMKO.
(E) Quantitation of Ki67+ cells frequency in eWAT
from HFD-fed CON and MMKO.
(F) Blood CCL2 (MCP-1) concentration from
HFD-fed CON and MMKO.
(G) Gene expression in BMDM from CON and
MMKO in the absence or presence of 10 ng/ml
LPS for 6 hr.
Data are means ± SEM. #p < 0.05 in groups, *p <
0.05, ***p < 0.001 versus CON.recruitment of CD11c+ ATMs to visceral adipose tissue, inflam-
mation, and metabolic dysfunction.
The Activation of Conventional CD4+ ATT Is Dependent
on Macrophage MHC II
We next examined the effect of MHC II deficiency in resident
ATMs on ATTs. The total amount of CD3+ lymphocytes in
eWAT was not significantly different between control and
MMKO mice on a ND or HFD (Figure 6A). While the quantity
of CD4+ ATTs was similar between lean WT and MMKO mice,
obese MMKO mice had fewer CD4+ ATTs in eWAT compared
with HFD controls (Figure 6B). In ND mice, there were no differ-
ences between MMKO and controls in the quantity of Tconv
and Treg in eWAT (gating shown in Figure S5A). However,
with HFD, Tconv expansion was blocked in MMKO mice (Fig-
ure 6C). In our cohorts, Tregs increased with HFD as a percent-
age of SVCs in control mice, but this was blunted in MMKO
mice (Figure S5B). Despite the selective reduction in CD4+
ATT in MMKO mice, no significant differences in proliferating
Ki-67+ CD4+ ATTs were observed in ND- or HFD-fed MMKO
mice compared with controls (Figure 6D). Lean MMKO mice612 Cell Reports 9, 605–617, October 23, 2014 ª2014 The Authorsdemonstrated an increase in the number
of CD8+ ATTs in eWAT (Figure 6B). With
a HFD, CD8+ ATTs increased to a similar
degree in control and MMKO mice.
Quantitation of naive, effector-memory
(E/M) and central-memory (C/M) CD4+
T cell subsets demonstrated similar
numbers of these subsets in ND fed
MMKO and control mice (Figures 6E–
6G), suggesting that homeostatic ATT
proliferation is MHC II independent. HFD
exposure decreased naive CD4+ ATTs
and increased E/M CD4+ ATTs in eWATin WT mice. In contrast, HFD-fed MMKO mice retained similar
percentages of naive T cells, as ND mice had a decrease in the
number of E/M ATTs. No significant changes in C/M ATTs
were observed between genotypes in either diet condition
(data not shown). These changes in CD4+ T cells were adipose
tissue specific as no differences in the frequency of CD4+
T cell, CD8+ T cells, Tconv, Treg, and proliferation were observed
in the spleens of obese control and MMKO mice (Figure S5C).
Gene expression analyses identified slight reductions Il2, a
critical regulator of T cell activation, in eWAT from MMKO mice
(Figure S4A). No differences in transcription factors critical
for Th1, Th2, and Th17 differentiation (Tbet, GATA3, RORg) or
polarization signals (Il4) were seen in whole eWAT from obese
WT and MMKO mice. Gene expression analysis of FACS
purified CD4+ T cells from eWAT from MMKO mice showed a
significant decrease in Ifng expression compared with WT (Fig-
ure 6H). This difference was specific to ATTs as Ifng expression
in splenic CD4+ T cells did not differ between MMKO and WT
mice (Figure S5C). These findings suggest that the maturation
of CD4+ ATTs with chronic HFD is dependent on ATM-derived
MHC II.
Figure 6. Macrophage-Specific MHC II Deficiency Reduces Obesity-Induced CD4+ ATT Accumulation and Maturation
(A and B) Quantitation of (A) CD3+ ATTs and (B) CD4+ and CD8+ ATTs in eWAT.
(C) Quantitation of Tconvs and Tregs in eWAT expressed as % SVCs (left) and as % CD4+ ATTs (right) in CON and MMKO.
(D) Frequency of proliferating Ki67+ CD4+ ATTs in eWAT.
(E) Representative flow cytometry plots gated on CD3+ CD4+ cells to quantify E/M (CD44high CD62L), C/M (CD44high CD62L+) and naive (CD44low CD62L+) CD4+
ATT subsets in eWAT.
(F) Quantitation of naive CD4+ ATT subsets in eWAT.
(G) Quantitation of E/M CD4+ ATT subsets in eWAT.
(H) Ifng gene expression in FACS-sorted CD4+ ATTs from HFD-fed CON and MMKO.
Data are means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 versus CON.Ablation of CD11c+ Cells Reduces CD4+ ATT
Accumulation and Proliferation in Obese Mice
The MMKO results demonstrate the importance of resident
CD11c ATMs in initiating ATT activation in response to obesity.
Since an increase in APC function is associated with the accu-
mulation of CD11c+ ATMs in obese mice, we examined the
importance of CD11c+ ATMs in sustaining T cell activation in es-
tablished obesity using a CD11c+ cell ablation model. Chimeric
CD11c-DTRmice were generated by transplanting bonemarrow
from CD11c-DTR transgenic mice (CD45.2) into lethally irradi-
ated wild-type recipients (CD45.1) (Figure 7A). Six weeks after
reconstitution, chimeric mice were fed a ND or HFD for 6 weeks.
Mice were then injected IP with PBS or diphtheria toxin (DT)
every other day for 2 weeks while continuing the diets. No signif-
icant changes in total body weight or eWATmass were observed
with DT injection (Figures S6A and S6B). Efficient ablation of
CD11c+ ATMs was confirmed by flow cytometry (Figure 7B).
As expected, in control mice, HFD increased total eWAT ATM
content and induced MHC IIhigh CD11c+ ATMs (Figures 7C and
7D). DT injection led to a slight decrease in total ATMs in leanCmice and significantly decreased the number of ATMs in HFD
mice. CD11c ablation did not alter fasting glucose levels or
glucose tolerance in ND-fedmice but normalized fasting glucose
levels and significantly improved glucose tolerance (Figures S6C
and S6D).
We next examined the effect of CD11c+ ATMablation on ATTs.
In PBS controls, the quantity of CD3+ ATTs in eWAT increased
in response to HFD (Figure 7E). Ablation of CD11c+ ATMs did
not alter CD3+ ATTs in ND-fed mice, but led to a significant
decrease in CD3+ ATTs in obese mice. This decrease was driven
by a decrease in CD4+ T cells (Figure 7F). Depletion of CD11c+
ATMs in HFD mice decreased the number of Tconv, while Tregs
increased in eWAT in the DT-treated group (Figure 7G). This
resulted in a significant decrease in the ratio of Tconv to Tregs
induced by with CD11c cell ablation in both diet groups. CD4+
ATT proliferation was assessed by BrDU incorporation. HFD
increased the proliferation of Tconv in controls (Figures 7H–7J).
Ablation of CD11c+ ATMs did not alter Tconv or Treg proliferation
in ND mice. However, depletion of CD11c+ ATMs in HFD mice
decreased Tconv proliferation and enhanced Treg proliferationell Reports 9, 605–617, October 23, 2014 ª2014 The Authors 613
Figure 7. Ablation of CD11c Decreases
CD4+ ATT Accumulation and Proliferation
in Response to Obesity
(A) Schematic diagram of experimental design of
DT-mediated ablation of CD11c-expressing cells.
Five mice per group were analyzed.
(B) Representative analysis of MHC II expression
in ATMs (CD11b+F480+) in eWAT from PBS or
DT-treated HFD-fed mice demonstrating loss of
MHC IIhigh cells with DT.
(C–F) Quantification of (C) ATMs, (D) CD11c+MHC
IIHI ATMs, (E) CD3+ ATTs, and (F) CD4+ ATTs in
eWAT.
(G) Quantification of Tconv and Treg (left) and the
ratio of Tconv to Treg (right) in eWAT.
(H) Representative analysis of CD4+ ATTs after
BrdU injection to identify proliferating cells. Cells
were gated on CD3+ CD4+ ATTs and then exam-
ined for FoxP3 and BrdU intracellular staining to
assess Tconv (Foxp3) and Treg (Foxp3+) ATT in
HFD-fed mice.
(I and J) Quantitation of proliferating (I) Tconv and
(J) Treg in eWAT.
(K) Quantitative RT-PCR analysis of eWAT from
PBS or DT-treated HFD mice.
Data are means ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001 versus PBS.
(L) Graphical model.in adipose tissue. Gene expression analysis of eWAT showed
that depletion of CD11c+ ATMs decreased expression of genes
associated with T cell activation (Il2 and Il12) and increased
expression of genes associated with Treg function (Foxp3,
GATA3, and Il10) (Figure 7K). Overall, these data suggest that
CD11c+ ATMs contribute to the maintenance Tconv ATTs at
the expense of Tregs in obese mice.
DISCUSSION
Our studies suggest important roles for both resident CD11c
and recruited CD11c+ ATMs as initiators and effectors of
adipose tissue inflammation via their communication with ATTs
via MHC II (Figure 7L). Chronic adipose tissue expansion leads
to events that compromised adipocyte function (e.g., hypoxia,
ER stress). MHC II+ resident ATMs (CD11c MGL1/CD301+
in mice) reside in close proximity to adipocytes and sample
the environment. ATTs transit throughout adipose tissue and
FALCs/milky spots, where they interact transiently with MHC II+614 Cell Reports 9, 605–617, October 23, 2014 ª2014 The AuthorsATMs. Interactions between ATTs and
ATMs are enhanced by cognate antigens
to potentiate T cell activation and conver-
sion of naive to effector/memory T cells.
MHC II in resident ATMs is required to
translate obesogenic cues into a matura-
tion of Tconv to this effector/memory
phenotype with increased IFNg ex-
pression. Disruption of class II signals
in resident ATMs prevents the down-
stream accumulation of proinflammatoryCD11c+ ATMs and preserves adipocyte insulin sensitivity.
Once established, CD11c+ ATMs support the continued activa-
tion and proliferation of Tconv at the expense of Tregs to pro-
mote insulin resistance.
Macrophage MHC II is not required for T cell maturation in pri-
mary and secondary lymphoid tissues, permitting us to identify
adipose tissue specific effects. Deletion of MHC II in macro-
phages (MMKO mice) does not alter ATT development consis-
tent with the MHC II-independent homeostatic proliferation of
tissue memory T cells (Surh and Sprent, 2008). However, loss
of macrophage class II restricted signals impairs their activation
with obesity demonstrating the importance of ongoing T cell ed-
ucation and selection in adipose tissue. This is consistent with
the unique profile of adipose tissue Tregs (Feuerer et al., 2009).
Consistent with reports of a role for MHC II in shaping CD8matu-
ration (Do et al., 2012), both MMKO and MHC IIKO mice have an
increase in adipose tissue CD8+ cells, suggesting that an in-
crease in CD8+ T cells in fat alone is not sufficient to potentiate
insulin resistance. Moreover, MHC IIKO mice have a significant
reduction in Tregs, yet are protected from obesity-induced
inflammation. This finding seems to be at oddswith other studies
demonstrating that Tregs are the sole protective factor in adi-
pose tissue that prevents inflammation. Our experience exam-
ining adipose tissue Tregs in lean and obese mice has differed
from other reports, as we do not consistently see a decrease in
adipose tissue Tregs with obesity as a percentage of CD4+
T cells. Because of the increase in total CD4+ T cells in the SVF
with obesity, we frequently observe an increase in Tregs as a
percentage of the SVF consistent with other reports (Deiuliis
et al., 2011; Winer et al., 2009). We are unsure of why our results
differ from other groups on this point, but differences in animal
husbandry conditions may contribute to Treg variation.
Our results with macrophage-specific MHC II deletion and
ablation of CD11c+ cells are complementary and reveal distinct
in vivo functions of ATM subtypes in T cell activation. While the
MMKOmice argue for a critical role for resident ATMs in the initi-
ation of T cell activation with obesity, CD11c-DTR experiments
suggest an important role for CD11c+ ATMs in sustaining this
activated state. Similar to other reports, ablation of CD11c+
ATMs in obese animals reverses insulin resistance and adipose
tissue inflammation (Patsouris et al., 2008). Our results link these
improvements to a decrease in the number and proliferative
capacity of Tconv and an increase in Tregs when CD11c+
ATMs are ablated. This demonstrates the importance of both
ATM subtypes in regulating T cell activation. Resident ATMs
participate in the initiation of inflammatory cascades via MHC II
to induce CD11c+ ATMs. However, in an established obese
inflammatory environment, CD11c+ ATMs play an important
role in sustaining conventional T cell proliferation and suppress-
ing Tregs.
Our data demonstrate a critical role ATMs play in priming CD4+
T cells and sustaining adaptive immune responses to obesity
in vivo and are consistent with in vitro studies (Moraes-Vieira
et al., 2014; Morris et al., 2013). Adipocytes have been shown
to induce MHC II gene expression with obesity and reactivate
antigen-primed T cells in vitro (Deng et al., 2013). Our studies
have found little evidence to support significant MHC II protein
expression on adipocytes in obese mice or human adipose
tissue samples relative to ATMs. By gene expression, macro-
phages account for >95% of the MHC II expression in adipose
tissue (residual MHC II+ adipose tissue DCs remain in our
MMKOmice), arguing that nonmacrophage cells such as adipo-
cytes play a minor role in MHC II expression in adipose tissue.
Our studies show that CD4+ ATTs interact with ATM-derived
MHC II much more frequently in their environment. However, it
is clear that regulation of T cell homeostasis is not purely MHC
II dependent, and it is likely that adipocyte derived signals influ-
ence T cell function and activation.
A major unanswered question in the field is the nature of the
antigen that is being presented by ATMs and sensed by
T cells. We can only speculate on the nature of this signal. The
identification of clonal expansion of CD4+ T cells is a feature of
atherosclerosis and type 1 diabetes; however, the identification
of key antigens in these disease settings has also been elusive.
Our studies suggest that therapeutic interventions that target
APC-T cell communication may play a role in the treatment
of insulin resistance and type 2 diabetes. In mice, MHC II anti-Cbody blockade decreasedCD4+ ATTs, but did not result in signif-
icant improvement in glucose tolerance (Morris et al., 2013). This
may be due to improper dosing or window of intervention and
will need to be revisited in light of our current work. Nonetheless,
our findings suggest an overlap between efforts to block TCR
signaling and costimulation in autoimmune diseases such as
multiple sclerosis and type 1 diabetes and obesity-associated
metainflammation (Podojil and Miller, 2009). It also implies that
antidiabetic treatments and therapies targeting adipokines
such as RBP4 may play critical roles in modulating APC function
of resident and CD11c+ ATMs.
An important implication of our MMKO mouse model is that
the ATMmay be a unique cells that if targeted can provide bene-
ficial effects in peripheral tissue responses without altering sys-
temic T cells. Macrophages are thought to have less potent APC
function than classical DCs. Our data suggest that adipose
tissue may be a unique environment dominated by ATMs with
strong APC activity that partner with T cells to establish an inter-
action network that perpetuates metainflammation.
EXPERIMENTAL PROCEDURES
Animal Studies
C57BL/6J, LysMCre (B6.129P2-Lyz2tm1cre1fo/J), MHC IIf/f (B6.129X1-H2-
Ab1tm1Koni/J), CD11c-DTR (B6.FVB-Tg(Itgax-DTR/EGFP)57Lan/J), and OT-II
(B6.Cg-Tg(TcraTcrb)425Cbn/J) mice were purchased from the Jackson
Laboratory. MHC IIKO (B6.129-H2-Ab1tm1Gru N12) and WT (B6.SJL-Ptprca/
BoyAiTac) male mice were purchased from Taconic. CD11c-mCherry mice
were kindly provided by Dr. Kamal Khanna (University of Connecticut). Macro-
phage-specific MMKOmice were generated by breeding LysM-Cre with MHC
IIf/f mice. Cre-negative MHC IIf/f littermates were used as control. Male mice
were ad libitum fed a normal diet (4.5% fat; PMI Nutrition International)
or fed a HFD consisting of 60% fat (Research Diets) beginning at 6 weeks
of age. All mice procedures were approved by the University Committee on
Use and Care of Animals at the University of Michigan and were conducted
in compliance with the Institute of Laboratory Animal Research Guide for the
Care and Use of Laboratory Animals.
Bone Marrow Transplantation
Bone marrow transplants were performed as described (Singer et al., 2013).
Reconstitution was confirmed 6 weeks after transplantation, and recipient an-
imals were fed either a ND or HFD for 8 weeks. For CD11c+ cell depletion, DT
(Sigma-Aldrich) was administered IP (4 ng/g body weight) into chimeric
CD11c-DTR mice every other day for 2 weeks while on diet. Control chimeric
mice were injected IP with PBS.
Metabolic Evaluation
Body weights were measured weekly, and body composition was determined
using a Minispec NMR analyzer (Bruker Optics). GTTs and ITTs were per-
formed after a 6 hr fast. For GTTs, mice were injected IP with D glucose
(0.7 g/kg). For ITTs, mice were injected IP with human insulin (1 U/kg). For
both GTTs and ITTs, blood glucose concentrations (mg/dl) were measured
0, 15, 30, 45, 60, 90, and 120 min after injection. Serum insulin (Crystal
Chem) and MCP-1 (R&D System) were measured by ELISA. Nonesterified
fatty acids in serum samples were measured using serum/plasma-free fatty
acid detection kits (Zen Bio). Total triglycerides were extracted from frozen
liver samples (200 mg) and measured by colorimetric enzyme assay.
Confocal Microscopy
After consent, human omental adipose tissue samples were collected intrao-
peratively from patients undergoing bariatric surgery at the University of Mich-
igan. All human use protocols were approved by the University of Michigan
Institutional Review Board. Immunofluorescence staining was performed asell Reports 9, 605–617, October 23, 2014 ª2014 The Authors 615
described (Martinez-Santiban˜ez et al., 2014) using the following antibodies:
anti-HLA-DR (clone LN3, eBioscience), anti-CD206 (clone 309210, R&D
Systems), anti-Caveolin (clone 2297, BD), anti-CD4 (clone A161A1, Bio-
legend). Images were collected using an Olympus Fluoview 100 laser scanning
confocal microscope.
Intravital Two-Photon Microscopy
The day before intravital microscopy, 2.5 3 106 CFSE-labeled OTII CD4+
T cells were adoptively transferred IP into recipient CD11c-mCherry mice.
BSA or OVA (100 mg/mouse) was administrated 2 hr before imaging. Mice
were anesthetized with pentobarbital (60 mg/kg body weight). Gonadal
adipose tissue was surgically exposed and positioned in custom-built heated
stage for intravital microscopy. Two-photon imagingwas performedwith Leica
5P MP confocal microscope (Leica Microsystems) equipped with 203 numer-
ical aperture objective with excitation with aMai-Tai Ti:Sapphire laser (Spectra
Physics) tuned to 800 nm. Emitted fluorescence was collected using a
two-channel nondescanned detector. For four-dimensional analysis of cell
trafficking, stacks of 20 section (z step = 1 mm) were acquired every 1 min to
provide an imaging volume of up to 20 mm in depth. Sequences of image
stacks were transformed into volume-rendered four-dimensional movies
using Imaris software (Bitplane), and the spot analysis was used for semiauto-
mated tracking of cell motility in three dimensions by using the parameters
of autoregressive motion as an algorithm 8 mm spot diameter and 20 mm
maximum distance. Imaris software (Bitplane) was used to calculate T cell
velocity, T cell displacement, and CD11c cell-CD4 cells interactions.
Isolation of Adipose Tissue SVCs and Flow Cytometry Analysis
SVCs from adipose tissues were isolated as previously described (Cho et al.,
2014).
Cells were incubated in Fc Block for 10min on ice and stained with indicated
antibodies for 30 min at 4C. Stained cells were washed twice in PBS and
fixed in 0.1% paraformaldehyde before analysis. For intracellular staining
and bromodeoxyuridine (BrDU), cells were stained as described before
(Morris et al., 2013). Analysis performed on FACSCanto II Flow Cytometer or
FACSAria III (BD Bioscciences) and analyzed with FlowJo software (Treestar).
Cell Culture
Bone marrow cells were isolated from mice by flushing of tibia and fibula and
differentiated into bone marrow-derived macrophages (BMDMs) as described
(Singer et al., 2013). Differentiation was confirmed by demonstrating F4/80
expression by flow cytometry. Cells were placed in 10% serum media for
24 hr prior to treatment with LPS (10 ng/ml) for 6 hr.
Gene-Expression Analysis
RNA from tissues and cells was extracted using RNeasy Midi Kits (QIAGEN),
and cDNA was generated from 0.5–1.0 mg total RNA using high-capacity
cDNA reverse transcription kits (Applied Biosystems). Power SYBR Green
PCR Master Mix (Applied Biosystems) and the StepOnePlus System (Applied
Biosystems) were used for real-time quantitative PCR. Arbp expression was
used as an internal control for data normalization. Samples were assayed in
duplicate, and relative expression was determined using the 2DDCT method.
Immunoblotting Analyses
Mice were fasted for 6 hr and stimulated with insulin (3 U/kg body weight) or
PBS IP. Liver and eWAT extracts were prepared 5 min after stimulation by
homogenization in lysis buffer containing 50 mM Tris (pH 7.5), 1% Nonidet
P-40, 150 mM NaCl, 2 mM EGTA, 1 mM Na3VO4, 100 mM NaF, 10 mM
Na4P2O7, and protease inhibitors. Proteins was separated by SDS-PAGE,
immunoblotted with indicated antibodies, and visualized using the Odyssey
infrared imaging system (Li-Cor Bioscience). Phospho-AKT (Ser473) and
AKT antibody were purchased from Cell Signaling Technology.
Statistical Analysis
All values are reported as mean ± SEM. Differences between groups were
determined using unpaired, two-tailed Student’s t test or one-way ANOVA
with Tukey post hoc tests with GraphPad Prism 5 software. p values less
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